ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sophiris Bio Receives Positive Feedback from EMA Regarding Prostate Cancer Clinical Trial Design americanpharmaceuticalreview
June 21, 2019Sophiris Bio has received formal scientific advice from the European Medicines Agency (EMA) regarding a proposed design of a Phase 3 clinical trial to evaluate the potential of topsalysin as a targeted focal therapy to treat patients with intermediate ris -
Sophiris Bio Releases Report on Patient Death
americanpharmaceuticalreview
August 31, 2018Sophiris Bio announced the conclusion of the ongoing investigation into the previously reported death of a patient in the company's Phase 2b trial for the treatment of localized prostate cancer is unlikely to be related to either topsalysin or the procedu
Pharma Sources Insight January 2025
